These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 7530337)

  • 21. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
    Sobek V; Balkow S; Körner H; Simon MM
    Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
    Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas.
    Legembre P; Moreau P; Daburon S; Moreau JF; Taupin JL
    Cell Death Differ; 2002 Mar; 9(3):329-39. PubMed ID: 11859415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas.
    Williams MS; Henkart PA
    J Immunol; 1996 Sep; 157(6):2395-402. PubMed ID: 8805638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
    Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
    J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas ligand, death gene.
    Pinkoski MJ; Green DR
    Cell Death Differ; 1999 Dec; 6(12):1174-81. PubMed ID: 10637433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
    Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
    Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.
    Memon SA; Moreno MB; Petrak D; Zacharchuk CM
    J Immunol; 1995 Nov; 155(10):4644-52. PubMed ID: 7594463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas ligand and Fas: a death factor and its receptor.
    Weissmann C
    Jpn J Cancer Res; 1994 Mar; 85(3):inside front cover. PubMed ID: 7514584
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases.
    Mariani SM; Matiba B; Bäumler C; Krammer PH
    Eur J Immunol; 1995 Aug; 25(8):2303-7. PubMed ID: 7545118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
    Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
    Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
    Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Fas death factor.
    Nagata S; Golstein P
    Science; 1995 Mar; 267(5203):1449-56. PubMed ID: 7533326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas ligand mediates activation-induced cell death in human T lymphocytes.
    Alderson MR; Tough TW; Davis-Smith T; Braddy S; Falk B; Schooley KA; Goodwin RG; Smith CA; Ramsdell F; Lynch DH
    J Exp Med; 1995 Jan; 181(1):71-7. PubMed ID: 7528780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression.
    Bulfone-Paus S; Rückert R; Krause H; von Bernuth H; Notter M; Pohl T; Tran TH; Paus R; Kunzendorf U
    Transplantation; 2000 Apr; 69(7):1386-91. PubMed ID: 10798759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
    Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
    Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Apoptosis and immunologic anomalies].
    Miyasaka N
    Nihon Naika Gakkai Zasshi; 1996 Oct; 85(10):1775-80. PubMed ID: 8999076
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
    Waring P; Müllbacher A
    Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.